973 related articles for article (PubMed ID: 26822896)
21. [Prophylactic mastectomy in women at high risk for breast cancer: indications and options].
Scheufler O; Fritschen Uv
Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):239-47. PubMed ID: 18716986
[TBL] [Abstract][Full Text] [Related]
22. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.
Petit JY; Veronesi U; Orecchia R; Luini A; Rey P; Intra M; Didier F; Martella S; Rietjens M; Garusi C; DeLorenzi F; Gatti G; Leon ME; Casadio C
Breast Cancer Res Treat; 2006 Mar; 96(1):47-51. PubMed ID: 16261402
[TBL] [Abstract][Full Text] [Related]
23. Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation.
Contant CM; Menke-Pluijmers MB; Seynaeve C; Meijers-Heijboer EJ; Klijn JG; Verhoog LC; Tjong Joe Wai R; Eggermont AM; van Geel AN
Eur J Surg Oncol; 2002 Sep; 28(6):627-32. PubMed ID: 12359199
[TBL] [Abstract][Full Text] [Related]
24. Nipple-sparing Mastectomy and Immediate Breast Reconstruction After Recurrence From Previous Breast Conservation Therapy.
Lee CH; Cheng MH; Wu CW; Kuo WL; Yu CC; Huang JJ
Ann Plast Surg; 2019 Jan; 82(1S Suppl 1):S95-S102. PubMed ID: 30431446
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.
Reding KW; Bernstein JL; Langholz BM; Bernstein L; Haile RW; Begg CB; Lynch CF; Concannon P; Borg A; Teraoka SN; Törngren T; Diep A; Xue S; Bertelsen L; Liang X; Reiner AS; Capanu M; Malone KE;
Breast Cancer Res Treat; 2010 Sep; 123(2):491-8. PubMed ID: 20135344
[TBL] [Abstract][Full Text] [Related]
26. Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation.
Ye F; Huang L; Lang G; Hu X; Di G; Shao Z; Cao A
Cancer Med; 2020 Mar; 9(5):1903-1910. PubMed ID: 31912664
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic mastectomy with immediate reconstruction combined with simultaneous laparoscopic salpingo-oophorectomy via a transmammary route: a novel surgical approach to female BRCA-mutation carriers.
Perabò M; Fink V; Günthner-Biller M; von Bodungen V; Friese K; Dian D
Arch Gynecol Obstet; 2014 Jun; 289(6):1325-30. PubMed ID: 24389920
[TBL] [Abstract][Full Text] [Related]
28. Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer.
Kaas R; Verhoef S; Wesseling J; Rookus MA; Oldenburg HS; Peeters MJ; Rutgers EJ
Ann Surg; 2010 Mar; 251(3):488-92. PubMed ID: 20134318
[TBL] [Abstract][Full Text] [Related]
29. Nipple-sparing mastectomy in BRCA1/2 mutation carriers: an interim analysis and review of the literature.
Yao K; Liederbach E; Tang R; Lei L; Czechura T; Sisco M; Howard M; Hulick PJ; Weissman S; Winchester DJ; Coopey SB; Smith BL
Ann Surg Oncol; 2015 Feb; 22(2):370-6. PubMed ID: 25023546
[TBL] [Abstract][Full Text] [Related]
30. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations.
Fatouros M; Baltoyiannis G; Roukos DH
Ann Surg Oncol; 2008 Jan; 15(1):21-33. PubMed ID: 17940826
[TBL] [Abstract][Full Text] [Related]
31. Oncologic outcomes and technical considerations of nipple-sparing mastectomies in breast cancer: experience of 425 cases from a single institution.
Shimo A; Tsugawa K; Tsuchiya S; Yoshie R; Tsuchiya K; Uejima T; Kojima Y; Shimo A; Hayami R; Nishikawa T; Yabuki Y; Kawamoto H; Sudo A; Fukuda M; Kanemaki Y; Maeda I
Breast Cancer; 2016 Nov; 23(6):851-860. PubMed ID: 26464007
[TBL] [Abstract][Full Text] [Related]
32. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
[TBL] [Abstract][Full Text] [Related]
33. Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case-Control Study.
Ryu JM; Park S; Paik HJ; Nam SJ; Kim SW; Lee SK; Yu J; Bae SY; Kim I; Bang SI; Mun GH; Pyon JK; Jeon BJ; Lee JE
Clin Breast Cancer; 2017 Jun; 17(3):204-210. PubMed ID: 28065399
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic.
Heemskerk-Gerritsen BA; Brekelmans CT; Menke-Pluymers MB; van Geel AN; Tilanus-Linthorst MM; Bartels CC; Tan M; Meijers-Heijboer HE; Klijn JG; Seynaeve C
Ann Surg Oncol; 2007 Dec; 14(12):3335-44. PubMed ID: 17541692
[TBL] [Abstract][Full Text] [Related]
35. Patient-Reported Outcome Measures may optimize shared decision-making for cancer risk management in BRCA mutation carriers.
van Egdom LSE; de Kock MA; Apon I; Mureau MAM; Verhoef C; Hazelzet JA; Koppert LB
Breast Cancer; 2020 May; 27(3):426-434. PubMed ID: 31832891
[TBL] [Abstract][Full Text] [Related]
36. New concept for immediate breast reconstruction for invasive cancers: feasibility, oncological safety and esthetic outcome of post-neoadjuvant therapy immediate breast reconstruction versus delayed breast reconstruction: a prospective pilot study.
Giacalone PL; Rathat G; Daures JP; Benos P; Azria D; Rouleau C
Breast Cancer Res Treat; 2010 Jul; 122(2):439-51. PubMed ID: 20502959
[TBL] [Abstract][Full Text] [Related]
37. Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriers.
Nemati Shafaee M; Goutsouliak K; Lin H; Bevers TB; Gutierrez-Barrera A; Bondy M; Arun B
Breast Cancer Res Treat; 2022 Nov; 196(1):143-152. PubMed ID: 36006499
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of mastectomy with immediate autologous latissimus dorsi breast reconstruction following neoadjuvant chemotherapy and radiation therapy: A single institution study of 111 cases of invasive breast carcinoma.
Paillocher N; Florczak AS; Richard M; Classe JM; Oger AS; Raro P; Wernert R; Lorimier G
Eur J Surg Oncol; 2016 Jul; 42(7):949-55. PubMed ID: 27134148
[TBL] [Abstract][Full Text] [Related]
39. Clinical and molecular characterization of BRCA-associated breast cancer: results from the DBCG.
Soenderstrup IMH; Laenkholm AV; Jensen MB; Eriksen JO; Gerdes AM; Hansen TVO; Kruse TA; Larsen MJ; Pedersen IS; Rossing M; Thomassen M; Ejlertsen B
Acta Oncol; 2018 Jan; 57(1):95-101. PubMed ID: 29164974
[TBL] [Abstract][Full Text] [Related]
40. International rates of breast reconstruction after prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers.
Semple J; Metcalfe KA; Lynch HT; Kim-Sing C; Senter L; Pal T; Ainsworth P; Lubinski J; Tung N; Eng C; Gilchrist D; Blum J; Neuhausen SL; Singer CF; Ghadirian P; Sun P; Narod SA;
Ann Surg Oncol; 2013 Nov; 20(12):3817-22. PubMed ID: 23740344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
